Skip to main content

Axol Bioscience introduces CiPA-validated human stem cell-derived ventricular cardiomyocytes to help improve drug discovery


via The Scientist RSS https://ift.tt/kIr9oEy Axol Bioscience Ltd. (Axol), an established provider of iPSC-derived cells, media, and characterization services for life science discovery, today announced that its human induced pluripotent stem cell (iPSC)-derived ventricular cardiomyocytes have undergone comprehensive in vitro pro-arrhythmia assay (CiPA) validation. Using this assay, the cells were shown to be suitable for measuring cardiotoxicity, offering scientists a robust cardiac model for drug discovery and screening. https://ift.tt/fOjB64I August 02, 2022 at 10:54PM

Comments

Popular posts from this blog

Doubts Raised Over Whether Mice Can Truly Inherit Immunity

via The Scientist RSS https://ift.tt/3fXmHT5 An independent lab fails to replicate results suggesting mammals exposed to pathogens could pass on immunological protections through epigenetic mechanisms. https://ift.tt/eA8V8J January 27, 2022 at 12:10AM

A New Smartphone Application Improves Memory Recall in Older Adults

via The Scientist RSS https://ift.tt/HF8yhqs Neuroscientists developed and tested a promising mobile app that mitigates age-related memory decline. https://ift.tt/kpa8Dct May 08, 2023 at 11:26PM

Alu Leap May Explain Why Apes Don't Have Tails

via The Scientist RSS https://ift.tt/3u3quo5 A transposable element that jumped into the TBXT gene, which is linked to tail morphology, appears to be to blame for our missing appendage. https://ift.tt/eA8V8J September 23, 2021 at 06:28PM